In pursuit of balance: renin–angiotensin–aldosterone system inhibitors and hyperkalaemia treatment
| Autor: | Edoardo Sciatti, Emilia D’Elia, Giulio Balestrieri, Salvatore D’Isa, Attilio Iacovoni, Michele Senni |
|---|---|
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | European Heart Journal Supplements. 25:C301-C305 |
| ISSN: | 1554-2815 1520-765X |
| Popis: | Hyperkalaemia is a life-threatening condition leading to significant morbidity and mortality. It is common in heart failure (HF) patients due to the disease itself, which often co-exists with chronic kidney disease and diabetes mellitus, the fluctuations in renal function, and the use of some drugs [i.e. renin–angiotensin–aldosterone system (RAAS) inhibitors]. In particular, hyperkalaemia opposes to their administration or up-titration, thus impacting on mortality. New K+ binders, namely, patiromer and sodium zirconium cyclosilicate, are an intriguing option to manage hyperkalaemia in HF patients, both to reduce its fatal effects and to let clinicians up-titrate RAAS inhibitors. Even if their real impact on strong outcomes is still to be determined, we hereby provide an overview of hyperkalaemia in HF and its current management. New trials are welcome to fill the gap in knowledge. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|